{"id":"https://openalex.org/W2109539100","doi":"https://doi.org/10.1001/archophthalmol.2008.562","title":"Improved Vision-Related Function After Ranibizumab vs Photodynamic Therapy: A Randomized Clinical Trial","display_name":"Improved Vision-Related Function After Ranibizumab vs Photodynamic Therapy: A Randomized Clinical Trial","alternate_titles":[],"publication_year":2009,"publication_date":"2009-01-12","ids":{"openalex":"https://openalex.org/W2109539100","doi":"https://doi.org/10.1001/archophthalmol.2008.562","mag":"2109539100","pmid":"https://pubmed.ncbi.nlm.nih.gov/19139332"},"language":"en","primary_location":{"id":"doi:10.1001/archophthalmol.2008.562","doi":"https://doi.org/10.1001/archophthalmol.2008.562","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archophthalmol.2008.562","pdf_url":null,"source":{"id":"https://openalex.org/S80523760","display_name":"Archives of Ophthalmology","issn_l":"0003-9950","issn":["0003-9950","1538-3601"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Ophthalmology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2109539100"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108102931","display_name":"Neil M. Bressler","orcid":"https://orcid.org/0009-0000-0845-6422","observed_orcids":["https://orcid.org/0009-0000-0845-6422"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Neil M. Bressler","raw_affiliation_strings":["Department of Ophthalmology, Retina Division, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2002, USA. nmboffice@jhmi.edu","Department of Ophthalmology, Retina Division, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2002, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Retina Division, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2002, USA. nmboffice@jhmi.edu","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]},{"raw_affiliation_string":"Department of Ophthalmology, Retina Division, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2002, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110145430","display_name":"Tom S. Chang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tom S Chang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068472015","display_name":"Jennifer T. Fine","orcid":"https://orcid.org/0000-0002-0524-7235","observed_orcids":["https://orcid.org/0000-0002-0524-7235"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer T Fine","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067278845","display_name":"Chantal Dolan","orcid":"https://orcid.org/0000-0002-2775-1512","observed_orcids":["https://orcid.org/0000-0002-2775-1512"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chantal M Dolan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5161666424","display_name":"James Ward","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James Ward","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5108102931"],"corresponding_institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"],"apc_list":null,"apc_paid":null,"fwci":12.4345,"has_fulltext":false,"cited_by_count":103,"citation_normalized_percentile":{"value":0.9911474,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"127","issue":"1","first_page":"13","last_page":"13"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":0.9700000286102295},{"id":"https://openalex.org/keywords/verteporfin-photodynamic-therapy","display_name":"verteporfin photodynamic therapy","score":0.925000011920929},{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nei-vfq-25","display_name":"NEI VFQ-25","score":0.9750000238418579},{"id":"https://openalex.org/keywords/intravitreal-anti-vegf-therapy","display_name":"intravitreal anti-VEGF therapy","score":0.8949999809265137},{"id":"https://openalex.org/keywords/vision-related-quality-of-life","display_name":"vision-related quality of life","score":0.6510000228881836},{"id":"https://openalex.org/keywords/anchor-trial","display_name":"ANCHOR trial","score":0.6669999957084656}],"concepts":[{"id":"https://openalex.org/C2781148688","wikidata":"https://www.wikidata.org/wiki/Q782318","display_name":"Verteporfin","level":4,"score":0.942004919052124},{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.9364665150642395},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8876762390136719},{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.7441960573196411},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.6375942230224609},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5881249308586121},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.48080411553382874},{"id":"https://openalex.org/C2781323092","wikidata":"https://www.wikidata.org/wiki/Q1428072","display_name":"Photodynamic therapy","level":2,"score":0.4748977720737457},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.31831443309783936},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2631797194480896},{"id":"https://openalex.org/C2781359195","wikidata":"https://www.wikidata.org/wiki/Q5105209","display_name":"Choroidal neovascularization","level":3,"score":0.2205435335636139},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1422751545906067},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.08781629800796509},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069579","descriptor_name":"Ranibizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077362","descriptor_name":"Verteporfin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005451","descriptor_name":"Fluorescein Angiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007267","descriptor_name":"Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010778","descriptor_name":"Photochemotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011166","descriptor_name":"Porphyrins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D014822","descriptor_name":"Vitreous Body","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017319","descriptor_name":"Photosensitizing Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018434","descriptor_name":"Sickness Impact Profile","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020256","descriptor_name":"Choroidal Neovascularization","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020256","descriptor_name":"Choroidal Neovascularization","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D020256","descriptor_name":"Choroidal Neovascularization","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1001/archophthalmol.2008.562","doi":"https://doi.org/10.1001/archophthalmol.2008.562","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archophthalmol.2008.562","pdf_url":null,"source":{"id":"https://openalex.org/S80523760","display_name":"Archives of Ophthalmology","issn_l":"0003-9950","issn":["0003-9950","1538-3601"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Ophthalmology","raw_type":"journal-article"},{"id":"pmid:19139332","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19139332","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of ophthalmology (Chicago, Ill. : 1960)","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W13634037","https://openalex.org/W66870926","https://openalex.org/W142950300","https://openalex.org/W150743151","https://openalex.org/W158455973","https://openalex.org/W1487528435","https://openalex.org/W1802218256","https://openalex.org/W1969775043","https://openalex.org/W2000333599","https://openalex.org/W2004681222","https://openalex.org/W2072754694","https://openalex.org/W2077949459","https://openalex.org/W2085712747","https://openalex.org/W2096060458","https://openalex.org/W2096653438","https://openalex.org/W2101421486","https://openalex.org/W2133644309","https://openalex.org/W2146870005","https://openalex.org/W2161217162","https://openalex.org/W2396393345","https://openalex.org/W2562671561","https://openalex.org/W4246147341"],"related_works":["https://openalex.org/W1969775043","https://openalex.org/W1964890261","https://openalex.org/W2085712747","https://openalex.org/W1984817372","https://openalex.org/W1964090567","https://openalex.org/W2085088582","https://openalex.org/W1982733715","https://openalex.org/W2012906786","https://openalex.org/W1987699263","https://openalex.org/W2068742492"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"compare":[2],"patient-reported":[3,240],"visual":[4,215,241],"function":[5,216],"in":[6,31,85,114,187,214,233],"those":[7,222],"with":[8,14,98,139,180,204,221,224],"neovascular":[9,234],"age-related":[10,235],"macular":[11,236],"degeneration":[12,237],"treated":[13,97,138,179,203,223],"ranibizumab":[15,43,99,181,205],"or":[16,38,47,105],"verteporfin":[17,46,52,225],"photodynamic":[18],"therapy":[19],"(PDT).":[20],"DESIGN:":[21],"Multicenter,":[22],"double-masked,":[23],"phase":[24],"3":[25],"trial":[26],"(ANCHOR).":[27],"Participants":[28],"were":[29,182,206],"randomized":[30],"a":[32,145],"1:1:1":[33],"ratio":[34],"to":[35,126,133,154,185,209,228],"receive":[36],"0.3":[37,165],"0.5":[39,106,157],"mg":[40,101,107,158,166],"of":[41,119,148,159,167],"intravitreal":[42],"plus":[44,50],"sham":[45,48],"injections":[49],"active":[51],"monthly.":[53],"The":[54],"National":[55],"Eye":[56],"Institute":[57],"Visual":[58],"Function":[59],"Questionnaire-25":[60],"(NEI":[61],"VFQ-25)":[62],"was":[63],"administered":[64],"at":[65,89],"baseline":[66,84],"and":[67,75,128,198],"1,":[68],"2,":[69],"3,":[70],"6,":[71],"9,":[72],"12,":[73],"18,":[74],"24":[76,176,218],"months.":[77,91],"MAIN":[78],"OUTCOME":[79],"MEASURE:":[80],"Mean":[81],"change":[82],"from":[83],"NEI":[86,115],"VFQ-25":[87,116],"scores":[88,118],"12":[90,94],"RESULTS:":[92],"At":[93,172],"months,":[95,177],"patients":[96,137,178],"(0.3":[100],"[n":[102,108],"=":[103,109,142,170],"137]":[104],"139])":[110],"had":[111,144],"mean":[112,146],"improvements":[113,213],"composite":[117],"5.9":[120],"(95%":[121,130,151],"confidence":[122],"interval":[123],"[CI],":[124],"3.6":[125],"8.3)":[127],"8.1":[129],"CI,":[131,152],"5.3":[132],"10.8)":[134],"points,":[135],"respectively;":[136],"PDT":[140],"(n":[141],"142)":[143],"improvement":[147],"2.2":[149],"points":[150],"-0.3":[153],"4.7;":[155],"vs":[156,164],"ranibizumab,":[160,168],"P":[161,169],"<":[162],".001;":[163],".003).":[171],"each":[173],"dose":[174],"through":[175,217],"more":[183,207],"likely":[184,208],"improve":[186,239],"most":[188],"subscales,":[189],"including":[190],"the":[191],"prespecified":[192],"subscales":[193],"(near":[194],"activities,":[195,197],"distance":[196],"vision-specific":[199],"dependency).":[200],"CONCLUSIONS:":[201],"Patients":[202],"report":[210],"clinically":[211],"meaningful":[212],"months":[219],"compared":[220],"PDT.":[226],"Application":[227],"Clinical":[229],"Practice":[230],"Ranibizumab":[231],"treatment":[232],"can":[238],"function.":[242],"Trial":[243],"Registration":[244],"clinicaltrials.gov":[245],"Identifier:":[246],"NCT00061594.":[247]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2109539100","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
